Researchers have identified natural killer cells as a potential therapeutic target for the treatment of neuropathic pain. The immune cells can selectively degenerate axons, allowing repair of damaged nerves.
Browsing: neuropathic pain
In this commentary, Turo Nurmikko focuses on the choice of surgical treatment in an unoperated patient with clinically established trigeminal neuralgia.
Researchers have discovered that a compound from marine snails can relieve pain in rodent models through a non-opioid pathway; this could present an alternative future treatment for chronic pain.
A recent study in mice has identified a chemical substance, OB-1, which dampens the perception of light touch and could be used to target neuropathic pain.
This article is a review of commonly used medications for chronic pelvic neuropathic pain disorders as well as an introduction to recent innovative developments in pain medicine.
Researchers have identified that microglia proliferation could have a role in neuropathic pain, indicating a new avenue for research into novel treatments.
This article brings together current thinking on minimally invasive procedures for neuropathic pain, including epidural steroid injections, peripheral nerve blocks and sympathetic nerve blocks, as well as neuroablative procedures and neuromodulation.
Microglia have increasingly been implicated in the pathogenesis of neuropathic pain, this article explores the relationship and the transcriptional factors driving the association.
Pain Management Commissioning Editor, Nick Ward, talks to diabetes expert Solomon Tesfaye (University of Sheffield) about his career and hopes for PL37, a novel dual enkephalinase inhibitor currently being trialled for treatment of diabetic neuropathy.
New study highlights a link between neurofeedback and chronic chemotherapy-induced peripheral neuropathy.